The Paradigm Shift from Traditional Scientific Platforms to Integrated Communications Plans

In the rapidly evolving biopharma landscape, the approach to scientific communications is undergoing a significant transformation. The shift from traditional scientific platforms to integrated communications plans (ICPs) is becoming increasingly crucial for ensuring cohesive and impactful messaging. This article delves into the components, implementation, and benefits of an ICP tailored for the biopharma industry, addressing the challenges of fragmented messaging and the need for a unified communication strategy...
Read More

Top Stories

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Health Literacy Month

Celebrating Health Literacy Month 2024:

October is Health Literacy Month, a reminder of the...
Omnichannel

The Quest for Omnichannel: Is Medical Affairs Ready?

Commercial and Medical Affairs must partner with each other to achieve the real benefits of...

A Guide to Creating a Robust Patient Engagement Strategy

Get started on effective patient engagement in your pharmaceutical or biotech company with our comprehensive...
Health Literacy

Health Literacy – Cactus Life Sciences Leads the Way

It’s our responsibility as an industry to emphasize the importance of health literacy and help...
Why the Healthcare Industry MUST Care About the Caregiver

Why the Healthcare Industry MUST Care about the Caregiver

Caregivers are vital in the treatment of a patient, whether at home or in a...

Beyond Words: How Voice, Graphics, and Video Are Changing the Way Researchers Reach Audiences

The growth and adoption of the internet and mobile technology have provided publishers and authors...
Stakeholder perspectives on digital scientific content

Digital Scientific Content: Stakeholder Perspectives

What do the different relevant stakeholder groups truly expect from pharma-generated scientific content?...

Learn more ABOUT our company.